This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics
May 11-14, 2026
Hynes Convention CenterBoston, MA

Caleb Culy
Senior Principal Chemist, Process Design and Development at Eli Lilly and Company
Speaker

Profile

Caleb Culy works as a Senior Principal Chemist at Eli Lilly and Company. He received his MS from Ball State University in 2016 in Chemistry. He joined Lilly in 2017 as a peptide chemist investigating structure-activity relationship (SAR) for peptide therapeutics. In 2021, Caleb transitioned to a process chemistry role in Lilly's development organization. He currently focuses on advancing innovative approaches to siRNA synthesis.

Agenda Sessions

  • Biocatalytic Synthesis of Oligonucleotides

    2:00pm